Emergence of synaptic and cognitive impairment in a mature-onset APP mouse model of Alzheimer’s disease

[1]  Afshin Ghavami,et al.  Differences in Synaptic Dysfunction Between rTg4510 and APP/PS1 Mouse Models of Alzheimer’s Disease , 2017, Journal of Alzheimer's disease : JAD.

[2]  O. Paulsen,et al.  Wild-Type, but Not Mutant N296H, Human Tau Restores Aβ-Mediated Inhibition of LTP in Tau−/− mice , 2017, Front. Neurosci..

[3]  M. Cecchini,et al.  Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease , 2016, Scientific Reports.

[4]  A. Smit,et al.  Dynamics of the mouse brain cortical synaptic proteome during postnatal brain development , 2016, Scientific Reports.

[5]  K. Rhodes,et al.  The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease , 2016, Nature.

[6]  K. Blennow,et al.  Amyloid precursor protein expression and processing are differentially regulated during cortical neuron differentiation , 2016, Scientific Reports.

[7]  Paul J. Harrison,et al.  Searching for cognitive enhancement in the Morris water maze: better and worse performance in D‐amino acid oxidase knockout (Dao −/−) mice , 2016, The European journal of neuroscience.

[8]  H. Rosenbrock,et al.  Age‐related synaptic dysfunction in Tg2576 mice starts as a failure in early long‐term potentiation which develops into a full abolishment of late long‐term potentiation , 2016, Journal of neuroscience research.

[9]  V. Perry,et al.  The use of human neurons for novel drug discovery in dementia research , 2016, Expert opinion on drug discovery.

[10]  Eric Karran,et al.  The Cellular Phase of Alzheimer’s Disease , 2016, Cell.

[11]  F. Edwards,et al.  First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression , 2015, Brain : a journal of neurology.

[12]  J. Cirrito,et al.  Genetic Modulation of Soluble Aβ Rescues Cognitive and Synaptic Impairment in a Mouse Model of Alzheimer's Disease , 2014, The Journal of Neuroscience.

[13]  M. Wolf,et al.  BDNF contributes to both rapid and homeostatic alterations in AMPA receptor surface expression in nucleus accumbens medium spiny neurons , 2014, The European journal of neuroscience.

[14]  F. Schmitt,et al.  Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models , 2014, Front. Genet..

[15]  J. Rawlins,et al.  Hippocampal synaptic plasticity, spatial memory and anxiety , 2014, Nature Reviews Neuroscience.

[16]  Michael J. Yetman,et al.  Wild-Type Neural Progenitors Divide and Differentiate Normally in an Amyloid-Rich Environment , 2013, The Journal of Neuroscience.

[17]  K. Blomgren,et al.  Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species , 2013, Progress in Neurobiology.

[18]  Henrik Zetterberg,et al.  Fluid biomarkers in Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[19]  J. Rawlins,et al.  Dissecting Spatial Knowledge from Spatial Choice by Hippocampal NMDA Receptor Deletion , 2012, Nature Neuroscience.

[20]  L. Buée,et al.  Neurotoxicity and Memory Deficits Induced by Soluble Low-Molecular-Weight Amyloid-β1–42 Oligomers Are Revealed In Vivo by Using a Novel Animal Model , 2012, The Journal of Neuroscience.

[21]  D. Dickson,et al.  Overlapping profiles of Aβ peptides in the Alzheimer's disease and pathological aging brains , 2012, Alzheimer's Research & Therapy.

[22]  D. Dickson,et al.  Overlapping profiles of Aβ peptides in the Alzheimer's disease and pathological aging brains , 2012, Alzheimer's Research & Therapy.

[23]  P. Salinas,et al.  The Secreted Wnt Antagonist Dickkopf-1 Is Required for Amyloid β-Mediated Synaptic Loss , 2012, The Journal of Neuroscience.

[24]  B. Strooper,et al.  The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes , 2012, Nature Neuroscience.

[25]  D. Bannerman,et al.  The role of habituation in hippocampus-dependent spatial working memory tasks: Evidence from GluA1 AMPA receptor subunit knockout mice , 2010, Hippocampus.

[26]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[27]  T. Golde,et al.  Robust Amyloid Clearance in a Mouse Model of Alzheimer's Disease Provides Novel Insights into the Mechanism of Amyloid-β Immunotherapy , 2011, The Journal of Neuroscience.

[28]  Julie R. Leitz,et al.  Tau Protein Is Required for Amyloid β-Induced Impairment of Hippocampal Long-Term Potentiation , 2011, The Journal of Neuroscience.

[29]  Todd E. Golde,et al.  Anti-Aβ Therapeutics in Alzheimer's Disease: The Need for a Paradigm Shift , 2011, Neuron.

[30]  L. Mucke,et al.  Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease , 2011, The Journal of Neuroscience.

[31]  Julie A. Harris,et al.  Transsynaptic Progression of Amyloid-β-Induced Neuronal Dysfunction within the Entorhinal-Hippocampal Network , 2010, Neuron.

[32]  G. Collingridge,et al.  A study of long-term potentiation in transgenic mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1 , 2010, Molecular Brain.

[33]  C. Hölscher,et al.  Synaptic Plasticity in the Hippocampus of a APP/PS1 Mouse Model of Alzheimer's Disease Is Impaired in Old but Not Young Mice , 2010, PloS one.

[34]  Songyang Zhou,et al.  Presynaptic and Postsynaptic Interaction of the Amyloid Precursor Protein Promotes Peripheral and Central Synaptogenesis , 2009, The Journal of Neuroscience.

[35]  John Hardy,et al.  The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal , 2009, Journal of neurochemistry.

[36]  P. Livrea,et al.  Disassembly of Shank and Homer Synaptic Clusters Is Driven by Soluble β-Amyloid1-40 through Divergent NMDAR-Dependent Signalling Pathways , 2009, PloS one.

[37]  H. Soininen,et al.  Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. , 2009, Archives of neurology.

[38]  Shaomin Li,et al.  Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory , 2008, Nature Medicine.

[39]  D. Selkoe,et al.  A Critical Function for β-Amyloid Precursor Protein in Neuronal Migration Revealed by In Utero RNA Interference , 2007, The Journal of Neuroscience.

[40]  Ralph A. Nixon,et al.  Cortical Plasticity in Alzheimer’s Disease in Humans and Rodents , 2007, Biological Psychiatry.

[41]  Anatol C. Kreitzer,et al.  Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease , 2007, Neuron.

[42]  W. Markesbery,et al.  Aβ solubility and deposition during AD progression and in APP×PS-1 knock-in mice , 2007, Neurobiology of Disease.

[43]  L. Mucke,et al.  Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.

[44]  F. Schmitt,et al.  Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment , 2007, Neurology.

[45]  R. Malinow,et al.  AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss , 2006, Neuron.

[46]  D. Selkoe,et al.  Effects of secreted oligomers of amyloid β‐protein on hippocampal synaptic plasticity: a potent role for trimers , 2006, The Journal of physiology.

[47]  R. Malenka,et al.  Synaptic scaling mediated by glial TNF-α , 2006, Nature.

[48]  J. Rawlins,et al.  T-maze alternation in the rodent , 2006, Nature Protocols.

[49]  H. Lester,et al.  Persistent Amyloidosis following Suppression of Aβ Production in a Transgenic Model of Alzheimer Disease , 2005, PLoS medicine.

[50]  A. Palmeri,et al.  Amyloid-β Peptide Inhibits Activation of the Nitric Oxide/cGMP/cAMP-Responsive Element-Binding Protein Pathway during Hippocampal Synaptic Plasticity , 2005, The Journal of Neuroscience.

[51]  D. Selkoe,et al.  Natural oligomers of the amyloid-β protein specifically disrupt cognitive function , 2005, Nature Neuroscience.

[52]  P. Andersen,et al.  Dissociation of experience-dependent and -independent changes in excitatory synaptic transmission during development of barrel cortex. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[53]  E. G. Jones,et al.  Switching of NMDA Receptor 2A and 2B Subunits at Thalamic and Cortical Synapses during Early Postnatal Development , 2004, The Journal of Neuroscience.

[54]  C. Herron,et al.  Nicotine enhances the depressive actions of A beta 1-40 on long-term potentiation in the rat hippocampal CA1 region in vivo. , 2003, Journal of neurophysiology.

[55]  Alison L. Barth,et al.  A developmental switch in the signaling cascades for LTP induction , 2003, Nature Neuroscience.

[56]  O. Vitolo,et al.  Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation: Reversibility by drugs that enhance cAMP signaling , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[57]  J. Collinge,et al.  Expression Pattern of a Mini Human PrP Gene Promoter in Transgenic Mice , 2002, Neurobiology of Disease.

[58]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[59]  H. Annoura,et al.  Progressive brain dysfunction following intracerebroventricular infusion of beta1–42-amyloid peptide , 2001, Brain Research.

[60]  B. Kagan,et al.  Impairment of hippocampal long‐term potentiation by Alzheimer amyloid β‐peptides , 2000 .

[61]  Q S Chen,et al.  Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides. , 2000, Journal of neuroscience research.

[62]  S. J. Martin,et al.  Synaptic plasticity and memory: an evaluation of the hypothesis. , 2000, Annual review of neuroscience.

[63]  J. Rawlins,et al.  Double dissociation of function within the hippocampus: a comparison of dorsal, ventral, and complete hippocampal cytotoxic lesions. , 1999, Behavioral neuroscience.

[64]  H. Schulman,et al.  Developmental expression of the CaM kinase II isoforms: ubiquitous γ- and δ-CaM kinase II are the early isoforms and most abundant in the developing nervous system , 1999 .

[65]  R. Nicoll,et al.  Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[66]  T. Bliss,et al.  Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice , 1999, Nature Neuroscience.

[67]  H. Schulman,et al.  Developmental expression of the CaM kinase II isoforms: ubiquitous gamma- and delta-CaM kinase II are the early isoforms and most abundant in the developing nervous system. , 1999, Brain research. Molecular brain research.

[68]  M. Won,et al.  Behavioral and Neuropathologic Changes Induced by Central Injection of Carboxyl‐Terminal Fragment of β‐Amyloid Precursor Protein in Mice , 1998, Journal of neurochemistry.

[69]  Pico Caroni,et al.  Overexpression of growth-associated proteins in the neurons of adult transgenic mice , 1997, Journal of Neuroscience Methods.

[70]  Nick C Fox,et al.  Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. , 1996, Brain : a journal of neurology.

[71]  B. Finlay,et al.  Linked regularities in the development and evolution of mammalian brains. , 1995, Science.

[72]  T. Bliss,et al.  A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.

[73]  M. Oster-Granite,et al.  Expression of the amyloid precursor protein gene in mouse oocytes and embryos. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[74]  D. Bonthron,et al.  PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model , 1991, Cell.

[75]  S. DeKosky,et al.  Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity , 1990, Annals of neurology.